Siteman Cancer Center at Washington University — St Louis, Missouri

Siteman Cancer Center at Washington University is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Siteman Cancer Center at Washington University has participated in 23 clinical trials with 8 currently active.

Therapeutic areas: AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I Diffuse Large B-Cell Lymphoma.

Sponsors: National Cancer Institute (NCI), University of Michigan Rogel Cancer Center, Ohio State University Comprehensive Cancer Center.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Siteman Cancer Center at Washington University?

Siteman Cancer Center at Washington University has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Siteman Cancer Center at Washington University conducted?

Siteman Cancer Center at Washington University has 23 clinical trials on record, with 8 currently active. Their work covers AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I Diffuse Large B-Cell Lymphoma.

Is Siteman Cancer Center at Washington University accredited by Crixeo Health?

Yes — Siteman Cancer Center at Washington University holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Siteman Cancer Center at Washington University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.